Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.21.2
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Common stock, shares authorized     45,000,000   45,000,000
Common stock, par value per share     $ 0.0001   $ 0.0001
Preferred stock, shares authorized     5,000,000   5,000,000
Preferred stock, par value per share     $ 0.0001   $ 0.0001
Proceeds from stock of sold     $ 4,599,055  
Proceeds from related parties $ 480,000        
Common Stock [Member] | Private Placement [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of stock sold   1,251,625      
Exercise Price   $ 4.00      
Proceeds from stock of sold   $ 5,006,500      
Proceeds from warrant exercised   $ 407,445      
Number of warrant purchased   89,730      
Warrant term 5 years 5 years      
Share price $ 4.00 $ 4.00